To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CUEDC2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
284 supporting clones for gene CUEDC2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AW067889 Bone, Hip .a 1 to 451 1 to 451       451/451
(100 %)
6 diff
(98.7 %id)
NM_024040.2   .a 3 to 1204 1 to 1202 exact RefSeq,   1202/1203
(99 %)
5 diff
(99.6 %id)
BM757008 Ascites, stomach .a 3 to 264 1 to 262       262/262
(100 %)
2 diff
(99.3 %id)
BM757046 Ascites, stomach .a 3 to 450 1 to 448       448/448
(100 %)
1 diff
(99.8 %id)
BM756951 Ascites, stomach .a 3 to 516 1 to 514       514/514
(100 %)
2 diff
(99.7 %id)
BM756813 Ascites, stomach .a 3 to 520 1 to 518   tiling clone,   518/518
(100 %)
2 diff
(99.7 %id)
CF141265 CNCAP(3)T-225 cell line, Prostate .a 14 to 510 1 to 497       497/497
(100 %)
4 diff
(99.2 %id)
BM841968 myeloma .a 14 to 517 1 to 504       504/504
(100 %)
5 diff
(99.1 %id)
BU165232 eye, retinoblastoma .a 21 to 820 12 to 813       802/908
(88 %)
19 diff
(98.0 %id)
TI_154171976   .a 21 to 689 88 to 757       670/1038
(64 %)
30 diff
(97.2 %id)
BM020458 astrocytoma grade IV, cell line, brain .a 28 to 694 1 to 673       673/1009
(66 %)
18 diff
(98.3 %id)
BQ233794 epithelioid carcinoma, Pancreas .a 29 to 532 1 to 509       509/1204
(42 %)
27 diff
(97.8 %id)
TI_59391245   .a 29 to 694 111 to 782       672/1008
(66 %)
17 diff
(98.4 %id)
BI759271 pooled colon, kidney, stomach .a 31 to 871 1 to 844       844/847
(99 %)
14 diff
(98.4 %id)
BM909099 astrocytoma grade IV, cell line, brain .a 31 to 741 1 to 715       715/1095
(65 %)
22 diff
(98.0 %id)
TI_57146249   .a 31 to 871 65 to 908       844/911
(92 %)
20 diff
(97.9 %id)
BG681365 skin, squamous cell carcinoma .a 32 to 774 1 to 746       746/747
(99 %)
13 diff
(98.3 %id)
BE736650 adenocarcinoma, Pancreas .a 37 to 690 1 to 659   AAA   659/1012
(65 %)
17 diff
(98.4 %id)
BM706980 eye, optic nerve .a 54 to 691 9 to 646       638/646
(98 %)
1 diff
(99.9 %id)
BI333268 cervical carcinoma cell line, cervix .a 63 to 774 1 to 709       709/712
(99 %)
6 diff
(99.2 %id)
BC000262 Eye, retinoblastoma .a 73 to 1192 1 to 1120 E227* tiling clone, available from MGC, AAA   1120/1120
(100 %)
2 diff
(99.9 %id)
BQ219470 epithelioid carcinoma, Pancreas .a 74 to 722 1 to 649       649/898
(72 %)
18 diff
(98.0 %id)
TI_57179107   .a 74 to 871 34 to 832       799/835
(95 %)
11 diff
(98.7 %id)
BF725312 eye, Iris .a 75 to 639 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BI771272 pooled lung and spleen .a 75 to 871 1 to 798       798/801
(99 %)
5 diff
(99.4 %id)
CF593767 Human Placenta, placenta .a 76 to 840 29 to 794       766/794
(96 %)
10 diff
(98.8 %id)
TI_44459616   .a 79 to 775 33 to 730       698/730
(95 %)
7 diff
(99.1 %id)
TI_57177346   .a 83 to 871 64 to 858       793/862
(91 %)
20 diff
(97.7 %id)
BI518742 leukocyte .a 84 to 775 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
TI_44159711   .a 84 to 819 26 to 761       736/761
(96 %)
7 diff
(99.1 %id)
BY995248   .a 84 to 727 1 to 644       644/644
(100 %)
6 diff
(99.1 %id)
CD580241 brain .a 85 to 578 1 to 495       495/830
(59 %)
9 diff
(99.0 %id)
CR994331 T-Lymphocytes .a 85 to 806 1 to 722       722/723
(99 %)
5 diff
(99.4 %id)
BG122016 adenocarcinoma, cell line, Liver .a 86 to 810 1 to 742       740/1192
(62 %)
35 diff
(97.1 %id)
BF238130 B-cells, primary B-cells from tonsils (cell line) .a 87 to 680 1 to 593       593/593
(100 %)
4 diff
(99.4 %id)
BF663564 B-cells, primary B-cells from tonsils (cell line) .a 87 to 929 1 to 842       842/1118
(75 %)
31 diff
(97.3 %id)
BM011704 brain, neuroblastoma, cell line .a 87 to 811 1 to 729       729/795
(91 %)
10 diff
(98.8 %id)
BQ231253 embryonal carcinoma, cell line, testis .a 87 to 949 1 to 865       863/865
(99 %)
16 diff
(98.2 %id)
CN256472 embryonic stem cells, cell lines H1, H7, andH9 .a 88 to 712 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
AW247525 lung, small cell carcinoma .a 88 to 577 10 to 499       490/499
(98 %)
6 diff
(98.8 %id)
BE779756 eye, retinoblastoma .a 88 to 747 1 to 666       666/1036
(64 %)
27 diff
(97.4 %id)
BI830853 brain, medulla .a 88 to 871 1 to 790       788/794
(99 %)
14 diff
(98.3 %id)
BM547794 brain, hippocampus .a 88 to 748 1 to 662       662/1132
(58 %)
7 diff
(99.4 %id)
BQ889863 brain, neuroblastoma, cell line .a 88 to 748 71 to 736       666/1061
(62 %)
28 diff
(97.4 %id)
CF127943 Chondrosarcoma Lung Metastasis cell lines, lung .a 88 to 830 1 to 743       743/743
(100 %)
9 diff
(98.8 %id)
TI_59380877   .a 88 to 811 109 to 836       728/794
(91 %)
9 diff
(98.9 %id)
TI_154193638   .a 88 to 1032 50 to 986 K170I A192S Q208X L217V Q218H ...     937/1056
(88 %)
43 diff
(96.0 %id)
BY798566 eye .a 89 to 667 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BI523966 pooled lung and spleen .a 89 to 819 1 to 731       731/731
(100 %)
1 diff
(99.9 %id)
BM452007 eye, retinoblastoma .a 89 to 897 1 to 817       817/834
(97 %)
13 diff
(98.5 %id)
BU501395 eye, normal pigmented retinal epithelium .a 89 to 1003 1 to 915       915/916
(99 %)
10 diff
(99.0 %id)
BQ894637 brain, neuroblastoma, cell line .a 89 to 985 1 to 896       896/897
(99 %)
10 diff
(98.9 %id)
BM505096 Pancreas, Purified pancreatic islet .a 90 to 592 9 to 511       503/511
(98 %)
7 diff
(98.7 %id)
CN256473 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 90 to 748 1 to 660       660/662
(99 %)
2 diff
(99.7 %id)
BX366552 Neuroblastoma Cot 25-normalized .a 90 to 594 1 to 506   fully sequenced,   506/506
(100 %)
27 diff
(94.7 %id)
BF338131 brain, glioblastoma with EGFR amplification .a 90 to 870 12 to 805       720/809
(88 %)
58 diff
(92.9 %id)
BG470650 eye, retinoblastoma .a 90 to 773 1 to 683       683/685
(99 %)
5 diff
(99.3 %id)
BU178073 melanotic melanoma, cell line, skin .a 90 to 1015 1 to 929       929/948
(97 %)
26 diff
(97.3 %id)
BQ677260 melanotic melanoma, cell line, skin .a 90 to 1001 1 to 921       921/921
(100 %)
19 diff
(98.0 %id)
BM788115 Ascites, stomach .a 90 to 592 1 to 503       503/503
(100 %)
5 diff
(99.1 %id)
BG104572 adrenal cortex carcinoma, cell line, adrenal gland .a 91 to 799 1 to 705       705/1050
(67 %)
22 diff
(98.0 %id)
BE253754 eye, retinoblastoma .a 92 to 748 1 to 655       655/662
(98 %)
3 diff
(99.6 %id)
BE251763 eye, retinoblastoma .a 92 to 694 1 to 611       611/611
(100 %)
18 diff
(97.1 %id)
CN256474 embryonic stem cells, cell lines H1, H7, andH9 .a 93 to 724 1 to 632       632/632
(100 %)
2 diff
(99.7 %id)
CN256476 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 93 to 766 1 to 674       674/674
(100 %)
4 diff
(99.5 %id)
BF308986 muscle, rhabdomyosarcoma .a 94 to 739 1 to 645       645/1141
(56 %)
16 diff
(98.6 %id)
BG827939 muscle, rhabdomyosarcoma .a 94 to 774 1 to 682       682/691
(98 %)
8 diff
(98.9 %id)
AW249226 lung, small cell carcinoma .a 95 to 611 10 to 526       517/526
(98 %)
6 diff
(98.9 %id)
AW411197 muscle, rhabdomyosarcoma .a 95 to 612 10 to 527       518/527
(98 %)
8 diff
(98.5 %id)
BF791624 adrenal cortex carcinoma, cell line, adrenal gland .a 95 to 811 13 to 731       719/1165
(61 %)
16 diff
(98.7 %id)
U46267 liver cell line, pancreatic cancer .a 95 to 316 1 to 222       222/222
(100 %)
4 diff
(98.2 %id)
BE887358 leiomyosarcoma, uterus .a 96 to 804 1 to 710       710/884
(80 %)
17 diff
(98.1 %id)
BG121269 adenocarcinoma, cell line, Liver .a 96 to 778 1 to 688       660/1246
(52 %)
26 diff
(98.0 %id)
CR592558 Neuroblastoma Cot 25-normalized .a 97 to 1194 1 to 1098 exact tiling clone,   1098/1098
(100 %)
0 diff
(100 %id)
AL527504 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 97 to 650 1 to 552   fully sequenced,   552/552
(100 %)
5 diff
(99.1 %id)
BQ636325 eye, retina .a 97 to 517 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
BQ637212 eye, retina .a 97 to 517 1 to 421       421/421
(100 %)
1 diff
(99.8 %id)
BG913518 anaplastic oligodendroglioma with 1p/19qloss, brain .a 97 to 854 1 to 759       759/763
(99 %)
9 diff
(98.9 %id)
BI769281 pooled lung and spleen .a 97 to 1051 1 to 957 D210G E211*     957/963
(99 %)
36 diff
(96.3 %id)
TI_57179049   .a 97 to 1051 33 to 989 D210G E211*     957/995
(96 %)
42 diff
(95.8 %id)
BG288090 bladder, transitional cell papilloma, cell line .a 98 to 864 1 to 775       773/971
(79 %)
30 diff
(97.0 %id)
DR158391 human embryonic stem cells differentiated toan early endodermal cell type .a 98 to 846 1 to 749       749/749
(100 %)
4 diff
(99.5 %id)
AA357582 Prostate .a 100 to 345 1 to 245       245/245
(100 %)
4 diff
(98.4 %id)
CN256468 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 100 to 666 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
BM803724 leiomyosarcoma, uterus .a 101 to 687 1 to 588       588/1130
(52 %)
9 diff
(99.3 %id)
BM547068 brain, hippocampus .a 101 to 1066 1 to 975 W193X P234A M235H A236G P237S ...     975/1058
(92 %)
28 diff
(97.4 %id)
CB268112 adipose .a 103 to 633 1 to 530       530/530
(100 %)
2 diff
(99.7 %id)
BQ215616 embryonal carcinoma, cell line, testis .a 104 to 769 1 to 669       669/814
(82 %)
16 diff
(98.1 %id)
BM698891 eye, fetal eyes .a 104 to 592 1 to 489       489/489
(100 %)
1 diff
(99.8 %id)
BQ640644 eye, retina .a 107 to 551 12 to 456       445/456
(97 %)
9 diff
(98.1 %id)
CR990437 T-Lymphocytes .a 107 to 944 1 to 840       840/841
(99 %)
4 diff
(99.6 %id)
BE885341 leiomyosarcoma, uterus .a 108 to 556 1 to 451       451/507
(88 %)
5 diff
(99.1 %id)
BE896379 melanotic melanoma, skin .a 108 to 568 1 to 466       466/1094
(42 %)
14 diff
(98.8 %id)
BG751041 eye, normal pigmented retinal epithelium .a 108 to 748 1 to 658       654/667
(98 %)
38 diff
(94.4 %id)
BI829255 brain, medulla .a 109 to 868 1 to 765       765/772
(99 %)
10 diff
(98.8 %id)
TI_57176175   .a 109 to 868 68 to 832       765/839
(91 %)
16 diff
(98.1 %id)
BE878590 large cell carcinoma, undifferentiated, lung .a 113 to 613 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
BE546539 cervical carcinoma cell line, cervix .a 114 to 740 1 to 624       624/698
(89 %)
11 diff
(98.5 %id)
BE900391 choriocarcinoma, placenta .a 114 to 925 1 to 804       808/806
(100 %)
20 diff
(97.6 %id)
AA090170   .a 116 to 395 1 to 276       278/276
(100 %)
13 diff
(95.3 %id)
BF312171 brain, neuroblastoma .a 117 to 871 1 to 757       757/762
(99 %)
12 diff
(98.5 %id)
BU149671 ductal carcinoma, cell line, Pancreas .a 117 to 871 1 to 762       762/959
(79 %)
14 diff
(98.6 %id)
BG337520 leiomyosarcoma cell line, uterus .a 119 to 960 1 to 840       840/1065
(78 %)
22 diff
(98.0 %id)
BG340215 leiomyosarcoma cell line, uterus .a 119 to 734 1 to 616       616/623
(98 %)
6 diff
(99.1 %id)
BU158009 ductal carcinoma, cell line, Pancreas .a 119 to 809 1 to 692       692/932
(74 %)
15 diff
(98.4 %id)
CX165866 human embryonic stem cells differentiated toan early endodermal cell type .a 119 to 906 1 to 788       788/788
(100 %)
0 diff
(100 %id)
BM453609 eye, retinoblastoma .a 120 to 1038 7 to 932 H232T R233G M235W A236L K238R ...     926/999
(92 %)
33 diff
(96.7 %id)
BU507461 leiomyosarcoma, uterus .a 120 to 432 1 to 314       314/982
(31 %)
7 diff
(99.3 %id)
CN256469 embryonic stem cells, cell lines H1, H7, andH9 .a 121 to 515 1 to 395       395/395
(100 %)
0 diff
(100 %id)
CN256470 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 121 to 526 1 to 405       405/405
(100 %)
1 diff
(99.8 %id)
BG759854 B-cells, primary B-cells from tonsils (cell line) .a 121 to 401 1 to 282       282/282
(100 %)
3 diff
(99.0 %id)
DB448642 testis .a 124 to 543 1 to 420       420/420
(100 %)
1 diff
(99.8 %id)
BE393699 endometrium, adenocarcinoma cell line, uterus .a 124 to 740 1 to 615       615/708
(86 %)
7 diff
(99.1 %id)
BF791501 adrenal cortex carcinoma, cell line, adrenal gland .a 127 to 811 13 to 694       686/1111
(61 %)
15 diff
(98.7 %id)
BE514735 adenocarcinoma cell line, ovary .a 136 to 880 1 to 735       735/819
(89 %)
25 diff
(97.0 %id)
CR611545 placenta .a 141 to 1160 1 to 1020 exact     1020/1020
(100 %)
0 diff
(100 %id)
CR619733 Neuroblastoma Cot 25-normalized .a 141 to 1190 1 to 1050 exact     1050/1050
(100 %)
0 diff
(100 %id)
AL517353 brain, neuroblastoma, neuroblastoma cells .a 141 to 479 1 to 342   fully sequenced,   342/342
(100 %)
7 diff
(98.0 %id)
BX374933 Neuroblastoma Cot 25-normalized .a 141 to 778 1 to 637   fully sequenced,   637/637
(100 %)
3 diff
(99.6 %id)
AL540797 placenta .a 141 to 733 1 to 593   fully sequenced,   593/593
(100 %)
0 diff
(100 %id)
BG470654 eye, retinoblastoma .a 141 to 629 75 to 578       511/579
(88 %)
18 diff
(96.9 %id)
CK822509 Pancreas, Purified pancreatic islet .a 141 to 590 1 to 454     Submitted on the opposite strand 458/454
(100 %)
7 diff
(98.5 %id)
BQ051879 blood, natural killer cells, cell line .a 141 to 811 120 to 802       681/1076
(63 %)
26 diff
(97.6 %id)
DN993662 brain, whole brain .a 141 to 759 20 to 638       625/638
(97 %)
7 diff
(99.0 %id)
BG830681 epithelioid carcinoma cell line, Pancreas .a 144 to 869 1 to 740       674/921
(73 %)
24 diff
(97.4 %id)
BG574712 breast, mammary adenocarcinoma, cell line .a 147 to 888 1 to 741       741/741
(100 %)
4 diff
(99.5 %id)
CN256475 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 152 to 573 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BX282665 lymph, lymphoma, cell line .a 153 to 641 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BM457768 lymph, lymphoma, cell line .a 153 to 1052 1 to 903 E267R A268G E269R A273X K279Q ...     903/914
(98 %)
9 diff
(99.1 %id)
AB025425   .a 154 to 1017 1 to 864 exact     864/864
(100 %)
0 diff
(100 %id)
AB232358   .a 154 to 1017 1 to 864 exact     864/864
(100 %)
0 diff
(100 %id)
BG324036 Kidney, renal cell adenocarcinoma .a 154 to 854 1 to 692       694/947
(73 %)
18 diff
(98.1 %id)
BI861883 breast, mammary adenocarcinoma, cell line .a 159 to 950 1 to 800       800/801
(99 %)
17 diff
(97.9 %id)
TI_57193374   .a 159 to 950 55 to 854       800/801
(99 %)
17 diff
(97.9 %id)
CF127784 Chondrosarcoma Lung Metastasis cell lines, lung .a 176 to 826 1 to 652       652/653
(99 %)
6 diff
(99.1 %id)
TI_154193462   .a 176 to 991 51 to 859   AAA   811/962
(84 %)
22 diff
(97.8 %id)
BE926972 colon_normal .a 177 to 342 175 to 10       166/175
(94 %)
0 diff
(100 %id)
BI039015 nervous_tumor .a 182 to 775 589 to 1       589/602
(97 %)
7 diff
(98.9 %id)
AW328374 cervix .a 201 to 782 10 to 592       583/592
(98 %)
7 diff
(98.9 %id)
BQ639942 eye, retina .a 216 to 818 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BU181943 eye, retinoblastoma .a 218 to 1085 1 to 874       874/880
(99 %)
11 diff
(98.8 %id)
BE379496 endometrium, adenocarcinoma cell line, uterus .a 240 to 916 39 to 721       681/912
(74 %)
24 diff
(97.4 %id)
BM753033 stomach .a 245 to 730 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
AA331243 Embryo, 8 weeks .a 266 to 446 1 to 180       180/181
(99 %)
6 diff
(96.7 %id)
AW962536   .a 268 to 745 1 to 478       478/557
(85 %)
15 diff
(97.4 %id)
AW962547   .a 268 to 753 1 to 486       486/526
(92 %)
21 diff
(96.1 %id)
BM562487 duodenal adenocarcinoma, cell line, small intestine .a 309 to 1162 1 to 862       862/1036
(83 %)
15 diff
(98.6 %id)
TI_154046407   .a 313 to 1192 980 to 107   AAA   874/982
(89 %)
25 diff
(97.5 %id)
BM700799 eye, human retina .a 315 to 719 9 to 413       405/413
(98 %)
9 diff
(97.9 %id)
BF841750 head_neck .a 327 to 645 25 to 342       318/342
(92 %)
8 diff
(97.7 %id)
DT220039 brain .a 328 to 840 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BQ933043 epidermoid carcinoma, cell line, lung .a 330 to 1101 1 to 775       775/882
(87 %)
15 diff
(98.3 %id)
BM824750 Ascites, stomach .a 331 to 830 1 to 500       500/500
(100 %)
0 diff
(100 %id)
CD513989 brain, Pituitary .a 339 to 1193 28 to 890       863/942
(91 %)
27 diff
(97.2 %id)
TI_154116416   .a 355 to 1192 934 to 99   AAA   837/940
(89 %)
22 diff
(97.7 %id)
BQ719075 sympathetic trunk .a 358 to 1175 1 to 824       824/894
(92 %)
13 diff
(98.6 %id)
BX376108 Neuroblastoma Cot 25-normalized .a 369 to 1140 772 to 1       772/902
(85 %)
13 diff
(98.6 %id)
CB410106 maxilla, pooled .a 385 to 840 1 to 456   fully sequenced,   456/456
(100 %)
1 diff
(99.8 %id)
BI160193 epithelioid carcinoma cell line, Pancreas .a 400 to 1126 1 to 737       735/738
(99 %)
18 diff
(97.6 %id)
T63468 lung .a 404 to 653 1 to 250       250/250
(100 %)
10 diff
(96.0 %id)
AA535180 invasive prostate tumor, Prostate .a 415 to 921 7 to 503       497/503
(98 %)
28 diff
(94.5 %id)
AA535766 invasive prostate tumor, Prostate .a 415 to 835 7 to 428       422/428
(98 %)
12 diff
(97.2 %id)
CR626050 Neuroblastoma Cot 25-normalized .a 430 to 1194 1 to 765       765/765
(100 %)
0 diff
(100 %id)
AL526169 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 430 to 1194 1 to 765   fully sequenced,   765/765
(100 %)
2 diff
(99.8 %id)
BX392276 Neuroblastoma Cot 25-normalized .a 431 to 1183 755 to 7       749/896
(83 %)
7 diff
(99.3 %id)
BI910814 leukocyte .a 432 to 1167 1 to 737       737/737
(100 %)
1 diff
(99.9 %id)
TI_57236474   .a 432 to 1167 28 to 764       738/764
(96 %)
7 diff
(99.1 %id)
BF752879 breast_normal .a 446 to 876 436 to 7     Submitted on the opposite strand 430/436
(98 %)
10 diff
(97.8 %id)
AL517352 brain, neuroblastoma, neuroblastoma cells .a 449 to 1163 714 to 1   fully sequenced,   714/714
(100 %)
58 diff
(91.9 %id)
Z33535   .a 453 to 823 1 to 370       370/370
(100 %)
2 diff
(99.5 %id)
BU175659 large cell carcinoma, lung .a 454 to 1192 1 to 739       739/909
(81 %)
6 diff
(99.4 %id)
BQ636564 eye, retina .a 471 to 1037 1 to 567       567/567
(100 %)
5 diff
(99.2 %id)
CN256477 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 473 to 1128 1 to 658       658/658
(100 %)
4 diff
(99.4 %id)
CD743077 Alveolar Macrophage, lung .a 482 to 1192 729 to 19   AAA   711/711
(100 %)
4 diff
(99.5 %id)
BQ009068 Chondrosarcoma, Left Pubic Bone .a 500 to 1192 712 to 19   AAA   694/694
(100 %)
1 diff
(99.9 %id)
BI856242 breast, mammary adenocarcinoma, cell line .a 504 to 1142 1 to 636       636/637
(99 %)
25 diff
(96.1 %id)
TI_57186110   .a 504 to 1142 41 to 676       636/637
(99 %)
25 diff
(96.1 %id)
BU625165 cell lines, Enchondroma .a 518 to 1192 696 to 19   AAA   678/678
(100 %)
4 diff
(99.5 %id)
BX366551 Neuroblastoma Cot 25-normalized .a 534 to 1169 643 to 1   fully sequenced,   643/643
(100 %)
18 diff
(97.3 %id)
BQ061560 lymph, lymphoma, cell line .a 535 to 1192 1 to 658   AAA   658/658
(100 %)
0 diff
(100 %id)
BQ018603 lung, Metastatic Chondrosarcoma .a 541 to 1192 670 to 19   AAA   652/659
(98 %)
5 diff
(99.3 %id)
BU629889 cell lines, Chondrosarcoma .a 544 to 1192 667 to 19   AAA   649/649
(100 %)
1 diff
(99.9 %id)
BQ774405 Chondrosarcoma Grade II, Left Pelvis .a 545 to 1192 666 to 19   AAA   648/648
(100 %)
4 diff
(99.4 %id)
CA412321 Chondrosarcoma Grade II, Left Pelvis .a 547 to 1192 664 to 19   AAA   646/646
(100 %)
2 diff
(99.7 %id)
CA421357 Bone, Enchondroma cell line .a 547 to 1192 664 to 19   AAA   646/646
(100 %)
1 diff
(99.9 %id)
BM910937 astrocytoma grade IV, cell line, brain .a 563 to 1192 644 to 15   AAA Submitted on the opposite strand 630/1093
(57 %)
14 diff
(98.8 %id)
TI_149289300   .a 565 to 1192 723 to 102   AAA   622/626
(99 %)
11 diff
(98.3 %id)
BF059069 fibrotheoma, ovary .a 587 to 1192 606 to 1       606/607
(99 %)
1 diff
(99.9 %id)
BF002772 Prostate .a 589 to 1198 617 to 8       610/617
(98 %)
0 diff
(100 %id)
BU625541 cell lines, Enchondroma .a 595 to 1192 616 to 19   AAA   598/598
(100 %)
0 diff
(100 %id)
D52414   .a 611 to 937 1 to 325       327/325
(100 %)
5 diff
(98.5 %id)
AL527503 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 620 to 1160 538 to 1   fully sequenced,   538/538
(100 %)
7 diff
(98.7 %id)
BM970868 lung .a 631 to 1192 578 to 19   AAA   560/560
(100 %)
4 diff
(99.3 %id)
TI_151742620   .a 632 to 1192 664 to 104   AAA   561/561
(100 %)
16 diff
(97.2 %id)
AV724535 hypothalamus .a 648 to 1194 1 to 547       547/566
(96 %)
2 diff
(99.7 %id)
AW062890 stomach .a 651 to 919 10 to 278       269/286
(94 %)
8 diff
(97.3 %id)
AW062922 stomach .a 651 to 919 10 to 278       269/286
(94 %)
7 diff
(97.6 %id)
AW062923 stomach .a 651 to 919 8 to 276       269/284
(94 %)
11 diff
(96.2 %id)
AW176399 colon .a 651 to 906 257 to 1       257/257
(100 %)
8 diff
(96.9 %id)
AW166290 cervix .a 661 to 1198 540 to 3       538/544
(98 %)
6 diff
(98.9 %id)
AW248805 lung, small cell carcinoma .a 664 to 1192 539 to 11   AAA   529/529
(100 %)
0 diff
(100 %id)
AW016020   .a 678 to 1192 532 to 18   AAA   515/515
(100 %)
1 diff
(99.9 %id)
BQ071428 brain, neuroblastoma, cell line .a 680 to 1198 1 to 519   AAA   519/519
(100 %)
0 diff
(100 %id)
AA311598   .a 693 to 1192 1 to 511       511/511
(100 %)
12 diff
(97.7 %id)
AA683537 heart .a 698 to 1192 492 to 1       492/492
(100 %)
3 diff
(99.4 %id)
AL540796 placenta .a 703 to 1160 456 to 1   fully sequenced,   456/456
(100 %)
10 diff
(97.9 %id)
AW067837 Bone, Hip .a 703 to 1184 490 to 9       482/490
(98 %)
1 diff
(99.8 %id)
EC453460 Prostate .a 704 to 802 6 to 102       97/102
(95 %)
7 diff
(93.2 %id)
BE222998 brain, oligodendroglioma .a 704 to 1194 493 to 3       491/493
(99 %)
0 diff
(100 %id)
BM921235 pooled brain, lung, testis .a 705 to 1192 20 to 507   AAA   488/507
(96 %)
7 diff
(98.7 %id)
W58708 heart .a 710 to 1116 33 to 439       407/446
(91 %)
21 diff
(95.3 %id)
EL947842 eyeball .a 714 to 1192 1 to 481   AAA   481/481
(100 %)
14 diff
(97.1 %id)
BX350867 Neuroblastoma Cot 25-normalized .a 717 to 1183 471 to 8   fully sequenced,   464/471
(98 %)
0 diff
(100 %id)
C14809   .a 724 to 1144 1 to 415       415/415
(100 %)
8 diff
(98.1 %id)
C14831   .a 724 to 1079 1 to 359       359/359
(100 %)
5 diff
(98.7 %id)
C15133   .a 724 to 1073 1 to 349       349/349
(100 %)
5 diff
(98.6 %id)
D61324   .a 724 to 1134 1 to 410       410/410
(100 %)
1 diff
(99.8 %id)
BU728292 eye, optic nerve .a 731 to 1192 480 to 19   AAA   462/462
(100 %)
0 diff
(100 %id)
BM504772 Pancreas, Purified pancreatic islet .a 732 to 1193 462 to 1       462/462
(100 %)
2 diff
(99.6 %id)
CK024214 brain/CNS, Human Brain - Frontal Cortex .a 738 to 1193 28 to 483   AAA   456/483
(94 %)
3 diff
(99.4 %id)
AA363125 ovary .a 740 to 911 1 to 172       172/172
(100 %)
0 diff
(100 %id)
AW954016   .a 741 to 1192 1 to 453       453/572
(79 %)
14 diff
(97.6 %id)
BQ319642 colon .a 742 to 1109 1 to 371       370/371
(99 %)
14 diff
(96.3 %id)
AI086483 anaplastic oligodendroglioma, brain .a 742 to 1192 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AA776682 schizophrenic brain S-11 frontal lobe .a 743 to 1183 1 to 440     Submitted on the opposite strand 440/440
(100 %)
6 diff
(98.7 %id)
AI669654 Prostate .a 743 to 1194 459 to 8       452/459
(98 %)
0 diff
(100 %id)
AA370462 Prostate .a 744 to 967 1 to 224       224/224
(100 %)
0 diff
(100 %id)
AA633738   .a 745 to 1192 446 to 1       446/452
(98 %)
3 diff
(99.4 %id)
BE208070 Kidney, renal cell adenocarcinoma .a 745 to 1192 468 to 21   AAA   448/460
(97 %)
34 diff
(92.7 %id)
D60282   .a 748 to 1192 445 to 1       445/462
(96 %)
0 diff
(100 %id)
AW082846 colon, moderately differentiated adenocarcinoma .a 748 to 1194 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AW245107 lung, small cell carcinoma .a 758 to 1192 445 to 11   AAA   435/435
(100 %)
3 diff
(99.4 %id)
BP398259 pancreatic islet .a 761 to 1192 1 to 432     Submitted on the opposite strand 432/432
(100 %)
5 diff
(98.9 %id)
AW058626 pooled .a 761 to 1198 465 to 27   AAA   439/439
(100 %)
14 diff
(96.9 %id)
BE049416 adenocarcinoma, Pancreas .a 764 to 1193 430 to 1       430/430
(100 %)
0 diff
(100 %id)
D80908 brain .a 777 to 1162 1 to 384       384/385
(99 %)
3 diff
(99.3 %id)
AL526113 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 779 to 1156 381 to 4   fully sequenced,   378/381
(99 %)
2 diff
(99.5 %id)
CB410105 maxilla, pooled .a 779 to 1192 461 to 48   fully sequenced, AAA   414/414
(100 %)
0 diff
(100 %id)
BF928728 nervous_tumor .a 782 to 1081 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
DB513780 testis .a 782 to 1192 1 to 410     Submitted on the opposite strand 410/410
(100 %)
1 diff
(99.8 %id)
AI381481 pooled .a 791 to 1192 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AA553512 Schwannoma tumor .a 792 to 1192 416 to 17   AAA   400/400
(100 %)
1 diff
(99.8 %id)
D60178   .a 810 to 1192 383 to 1       383/389
(98 %)
1 diff
(99.8 %id)
AA527484 colon .a 810 to 1192 411 to 29   AAA   383/447
(85 %)
3 diff
(99.4 %id)
AW374210 breast .a 812 to 1027 255 to 41       215/265
(81 %)
0 diff
(100 %id)
AI400080 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 816 to 1194 380 to 2       379/380
(99 %)
0 diff
(100 %id)
AA602403 normal prostate, Prostate .a 820 to 1158 388 to 51   AAA   338/378
(89 %)
0 diff
(100 %id)
AI160652 uterus .a 820 to 1192 397 to 24   AAA   374/426
(87 %)
22 diff
(94.9 %id)
AA648722 germinal center B cell .a 830 to 1151 321 to 1       321/321
(100 %)
4 diff
(98.8 %id)
AI368082 adenocarcinoma, colon .a 835 to 1192 358 to 1       358/358
(100 %)
0 diff
(100 %id)
D60200   .a 839 to 1192 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AI023340 liver and spleen .a 843 to 1188 350 to 5       346/350
(98 %)
0 diff
(100 %id)
AA303129 uterus .a 844 to 1198 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AA015607 heart .a 844 to 1192 380 to 33   AAA   348/348
(100 %)
1 diff
(99.8 %id)
F21963 pectoral muscle (after mastectomy) .a 848 to 1025 1 to 180       180/180
(100 %)
2 diff
(98.9 %id)
AI269255 Kidney .a 851 to 1192 362 to 21   AAA   342/342
(100 %)
9 diff
(97.4 %id)
AW662376 colon, moderately-differentiated adenocarcinoma .a 854 to 1198 347 to 3       345/347
(99 %)
0 diff
(100 %id)
T63617 lung .a 855 to 1152 293 to 1       293/293
(100 %)
6 diff
(98.0 %id)
AI914984 pooled .a 857 to 1192 335 to 1       335/335
(100 %)
5 diff
(98.6 %id)
AW879583 ovary .a 865 to 1061 1 to 198       198/198
(100 %)
13 diff
(93.5 %id)
AI261947 adenocarcinoma, colon .a 886 to 1193 347 to 40       308/347
(88 %)
0 diff
(100 %id)
AW411198 muscle, rhabdomyosarcoma .a 903 to 1192 360 to 71   AAA   290/290
(100 %)
24 diff
(91.8 %id)
AA652967 normal prostate, Prostate .a 915 to 1160 246 to 1       246/246
(100 %)
0 diff
(100 %id)
AA532544 normal prostate, Prostate .a 928 to 1192 265 to 1       265/265
(100 %)
0 diff
(100 %id)
AA679920 ovary .a 930 to 1193 264 to 1       264/264
(100 %)
2 diff
(99.3 %id)
BU607584 Human Lung Epithelial cells, lung .a 944 to 1192 267 to 19   AAA   249/258
(96 %)
0 diff
(100 %id)
AA331259   .a 959 to 1192 246 to 11   AAA Submitted on the opposite strand 236/236
(100 %)
2 diff
(99.2 %id)
BG912022 anaplastic oligodendroglioma with 1p/19qloss, brain .a 963 to 1192 1 to 230   AAA   230/230
(100 %)
0 diff
(100 %id)
AI194082 lung .a 1005 to 1192 212 to 25   AAA   188/188
(100 %)
7 diff
(96.3 %id)
AI888927 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1047 to 1192 161 to 16   AAA   146/147
(99 %)
2 diff
(98.7 %id)
C21407   .a 1055 to 1193 1 to 139       139/141
(98 %)
4 diff
(97.2 %id)
AI241654 brain, tumor, 5 pooled (see description) .a 1065 to 1192 150 to 23   AAA   128/128
(100 %)
3 diff
(97.7 %id)
AA905057 pooled .a 1095 to 1194 101 to 2       100/101
(99 %)
0 diff
(100 %id)
BE515185 endometrium, adenocarcinoma cell line, uterus .b 1 to 871 1 to 873   tiling clone,   875/1022
(85 %)
32 diff
(96.9 %id)
BU155827 melanotic melanoma, skin .b 17 to 872 1 to 862 W193X G257R N265E E267W A268R ... tiling clone,   862/865
(99 %)
11 diff
(98.8 %id)
BU158708 large cell carcinoma, lung .c 1 to 750 6 to 762 G215E K216X E217G E218R P220A ... tiling clone,   757/930
(81 %)
19 diff
(98.0 %id)
BI760706 pooled colon, kidney, stomach .d 1 to 803 1 to 803 E123D T124* tiling clone,   803/808
(99 %)
9 diff
(98.9 %id)
TI_57147852   .d 1 to 803 29 to 831 E123D T124*     803/836
(96 %)
15 diff
(98.3 %id)
BM129558 Islets of Langerhans, Pancreas .e 1 to 550 1 to 550 exact tiling clone,   550/550
(100 %)
0 diff
(100 %id)
CN256471 embryonic stem cells, DMSO-treated H9 cellline .f 1 to 528 1 to 528   tiling clone,   528/528
(100 %)
0 diff
(100 %id)
BG818736 anaplastic oligodendroglioma with 1p/19qloss, brain .f 9 to 721 1 to 711 G74A T75Q I76*     711/711
(100 %)
6 diff
(99.2 %id)
BM782365 stomach .f 448 to 1056 1 to 609   tiling clone,   609/609
(100 %)
0 diff
(100 %id)
AI910870 pooled .f 808 to 1337 530 to 1   tiling clone,   530/530
(100 %)
1 diff
(99.9 %id)
CA502914 Human Lung Epithelial cells, lung .g 1 to 733 750 to 19 exact tiling clone, AAA   732/732
(100 %)
7 diff
(99.1 %id)
AK094695 amygdala .h-u 1 to 2459 2 to 2456   tiling clone, available from FLJ,   2456/2458
(99 %)
8 diff
(99.7 %id)
DA164254 amygdala .h-u 1 to 569 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AL709932 human skeletal muscle .h-u 5 to 254 1 to 249       249/249
(100 %)
5 diff
(98.0 %id)
BF847596 lung_normal .h-u 430 to 578 1 to 147       147/150
(98 %)
11 diff
(92.7 %id)
DB302315 amygdala .h-u 1924 to 2459 534 to 3   tiling clone,   532/534
(99 %)
0 diff
(100 %id)
BX489938 human skeletal muscle .h-u 2070 to 2458 407 to 20   AAA   388/388
(100 %)
17 diff
(95.7 %id)
W79167 heart .i 1 to 414 1 to 420 A27X K29R E30R A31P K33R ... tiling clone,   420/422
(99 %)
17 diff
(96.0 %id)
AF086406   .i 2 to 412 1 to 411   tiling clone, AAA   411/411
(100 %)
0 diff
(100 %id)
W74296 heart .i 2 to 412 411 to 1       411/412
(99 %)
4 diff
(99.1 %id)
CF124781 CNCAP(3)T-225 cell line, Prostate .j 1 to 339 39 to 377 exact tiling clone, AAA   339/377
(89 %)
6 diff
(98.5 %id)
BF346454 anaplastic oligodendroglioma with 1p/19qloss, brain .j 15 to 683 1 to 668 exact tiling clone,   668/668
(100 %)
6 diff
(99.2 %id)
BX489544   Gene CUEDC2, variant not shown         This clone was ignored    
BX489545   Gene CUEDC2, variant not shown         This clone was ignored    
AI742637 pooled Gene CUEDC2, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI